Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol and Genistein in Early Stage Prostate Cancer
NCT01325311Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2011
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Cholecalciferol + Genistein with Placebo (2 arms). Primary endpoints: Prostate Tissue Steady State Concentrations of Calcitriol at Day 35 and Detectability of Calcitriol Levels in Tissue at Day 35. Started Dec 2011; status: completed.
02
Drugs
vitamin dgenistein
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01325311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325311.